SCHEMBL678831

SCHEMBL678831

CS(=O)(=O)NC(=O)c1ccc(Oc2cccc(F)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 4/20 0.52
▸ MCL1 Q07820 4/20 0.52
▸ KDM4E B2RXH2 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ SCN9A Q15858 3/20 0.48
▸ SCN2B O60939 1/20 0.48
▸ SCN1A P35498 1/20 0.48
▸ SCN1B Q07699 1/20 0.48
▸ SCN5A Q14524 1/20 0.48
▸ MMP1 P03956 1/20 0.46
▸ MMP13 P45452 1/20 0.46
▸ SNCA P37840 1/20 0.45
▸ P2RY14 Q15391 1/20 0.45
▸ GCK P35557 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.44
▸ PTPN1 P18031 1/20 0.44
▸ PGR P06401 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679760 0.87 BCL2L1 (0.49) BCL2L1MCL1SCN9ASCN2BSCN1A
SCHEMBL365989 0.87 BCL2L1 (0.50) BCL2L1MCL1KDM4EALDH1A1MMP1
SCHEMBL703171 0.86 BCL2L1 (0.59) BCL2L1MCL1SCN9ASCN2BSCN1A
SCHEMBL680466 0.85 EZH2 (0.54) BCL2L1MCL1ALDH1A1SCN9ASCN2B
SCHEMBL680286 0.85 PGR (0.60) BCL2L1MCL1ALDH1A1SCN9ASCN2B
SCHEMBL678903 0.84 BCL2L1 (0.52) BCL2L1MCL1ALDH1A1SCN9ASCN2B
SCHEMBL680206 0.83 SOS1 (0.50) BCL2L1MCL1SCN9AMMP13PTPN1
SCHEMBL680717 0.83 MAPK14 (0.56) MCL1KDM4ESCN9ASCN2BSCN1A
SCHEMBL16319187 0.83 MAPK14 (0.56) BCL2L1MCL1SCN9ASCN5AHDAC8
SCHEMBL30147521 0.83 HPGD (0.67) KDM4EALDH1A1MMP13SNCAP2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593427-B1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN PFIZER LTD (GB) 2014-12-24 — — EP disclosed
US-20120010207-A1 Chemical Compounds PFIZER LIMITED (GB) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010207-A1 Chemical Compounds SCN1A, SCN1B, SCN7A BCL2L1 3284/4885MCL1 2739/4885KDM4E 3006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback